Patent Lens is a worldwide, open-access, free full-text patent informatics
resource. It serves as the cyberinfrastructure platform for
the Initiative for Open Innovation
(IOI). Why are we doing this?
- Search and retrieve the full-text of over ten million patent documents from
US, Europe, Australia and WIPO, their status and counterparts up to 70
countries.
- Landscapes are 'interpretation maps' that analyze volumes of specialized
patent, scientific, technical and business data around particular topics into a
more navigable form.
Transparency of the worldwide patent system must be an international public
good; This is your resource, and we need your help to
keep it open and free.
|
|
Patent Lens New Features
|
- Patent search interface in Chinese (中文), English, Russian
(Русский), and French.
- Full text of PCT applications now searchable in Chinese, English, French,
German, Japanese, Korean, Russian and Spanish.
- Full text of EPO patents now searchable in English, French and German.
- Search for lapsed, abandoned or expired US Patents.
- Visualize Patent Families with new graphical trees as PDFs.
- Patent Landscapes on
Influenza Genes,
Rice Genome and
Adjuvants
now online.
-
Protein & DNA Sequence searching of over 80
million sequences from worldwide patent collections.
|
|
Selected Media
|
Newsclick (India), India May 8, 2010
GM Foods and Bt Brinjal: Interview with Prof. Richard Jefferson, Cambia
ABC Lateline, Australia April 13, 2010
Patent battle brewing over plant genes
Intellectual Property Watch, Kenya October 19, 2009
CIO, Australia October 6, 2009
|
|
Nature Biotechnology editorial, May 2006 (info)
The ability to interpret and filter intellectual property (IP) has never
been more important...CAMBIA's Patent Lens is a giant leap in the right
direction"
|
|
Red Herring Cover-story and editorial, April 17,
2006 (info)
Patent transparency is the lifeblood of the new open source"
-Influential IT mag features CAMBIA's role in changing the face of life
sciences innovation.
(info)
|
|
» More News/Press items...
|
|
|
There are no comments.